246 related articles for article (PubMed ID: 17573238)
1. Alteration of motor nerve recovery cycle in multiple sclerosis.
Boërio D; Créange A; Hogrel JY; Lefaucheur JP
Clin Neurophysiol; 2007 Aug; 118(8):1753-8. PubMed ID: 17573238
[TBL] [Abstract][Full Text] [Related]
2. Neuromuscular excitability properties in myotonic dystrophy type 1.
Boërio D; Hogrel JY; Bassez G; Lefaucheur JP
Clin Neurophysiol; 2007 Nov; 118(11):2375-82. PubMed ID: 17890147
[TBL] [Abstract][Full Text] [Related]
3. Brain excitability changes in the relapsing and remitting phases of multiple sclerosis: a study with transcranial magnetic stimulation.
Caramia MD; Palmieri MG; Desiato MT; Boffa L; Galizia P; Rossini PM; Centonze D; Bernardi G
Clin Neurophysiol; 2004 Apr; 115(4):956-65. PubMed ID: 15003779
[TBL] [Abstract][Full Text] [Related]
4. A reappraisal of various methods for measuring motor nerve refractory period in humans.
Boërio D; Hogrel JY; Créange A; Lefaucheur JP
Clin Neurophysiol; 2005 Apr; 116(4):969-76. PubMed ID: 15792907
[TBL] [Abstract][Full Text] [Related]
5. Rapid-onset central motor plasticity in multiple sclerosis.
Zeller D; aufm Kampe K; Biller A; Stefan K; Gentner R; Schütz A; Bartsch A; Bendszus M; Toyka KV; Rieckmann P; Classen J
Neurology; 2010 Mar; 74(9):728-35. PubMed ID: 20194911
[TBL] [Abstract][Full Text] [Related]
6. The refractory period of fast conducting corticospinal tract axons in man and its implications for intraoperative monitoring of motor evoked potentials.
Novak K; de Camargo AB; Neuwirth M; Kothbauer K; Amassian VE; Deletis V
Clin Neurophysiol; 2004 Aug; 115(8):1931-41. PubMed ID: 15261873
[TBL] [Abstract][Full Text] [Related]
7. Post-exercise facilitation and depression of motor evoked potentials to transcranial magnetic stimulation: a study in multiple sclerosis.
Perretti A; Balbi P; Orefice G; Trojano L; Marcantonio L; Brescia-Morra V; Ascione S; Manganelli F; Conte G; Santoro L
Clin Neurophysiol; 2004 Sep; 115(9):2128-33. PubMed ID: 15294215
[TBL] [Abstract][Full Text] [Related]
8. F-wave characteristics as surrogate markers of spasticity in patients with secondary progressive multiple sclerosis.
Argyriou AA; Karanasios P; Makridou A; Makris N
J Clin Neurophysiol; 2010 Apr; 27(2):120-5. PubMed ID: 20505376
[TBL] [Abstract][Full Text] [Related]
9. Multimodality-evoked potential study of anti-aquaporin-4 antibody-positive and -negative multiple sclerosis patients.
Watanabe A; Matsushita T; Doi H; Matsuoka T; Shigeto H; Isobe N; Kawano Y; Tobimatsu S; Kira J
J Neurol Sci; 2009 Jun; 281(1-2):34-40. PubMed ID: 19339021
[TBL] [Abstract][Full Text] [Related]
10. Axonal excitability properties in amyotrophic lateral sclerosis.
Vucic S; Kiernan MC
Clin Neurophysiol; 2006 Jul; 117(7):1458-66. PubMed ID: 16759905
[TBL] [Abstract][Full Text] [Related]
11. 'Neurographic' palmaris brevis sign in type II degrees ulnar neuropathy at wrist.
Morini A; Della Sala WS; Bianchini G; Cannova R; Nostro MC; Orrico D
Clin Neurophysiol; 2005 Jan; 116(1):43-8. PubMed ID: 15589182
[TBL] [Abstract][Full Text] [Related]
12. Determinants of disability in multiple sclerosis at various disease stages: a multiparametric magnetic resonance study.
Pulizzi A; Rovaris M; Judica E; Sormani MP; Martinelli V; Comi G; Filippi M
Arch Neurol; 2007 Aug; 64(8):1163-8. PubMed ID: 17698707
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of the six-minute walk in multiple sclerosis subjects and healthy controls.
Goldman MD; Marrie RA; Cohen JA
Mult Scler; 2008 Apr; 14(3):383-90. PubMed ID: 17942508
[TBL] [Abstract][Full Text] [Related]
14. [Evaluation of polyneuropathy severity in chronic renal failure patients on continuous ambulatory peritoneal dialysis or on maintenance hemodialysis].
Janda K; Stompór T; Gryz E; Szczudlik A; Drozdz M; Kraśniak A; Sułowicz W
Przegl Lek; 2007; 64(6):423-30. PubMed ID: 18159852
[TBL] [Abstract][Full Text] [Related]
15. Supratentorial ischemic stroke: more than an upper motor neuron disorder.
van Kuijk AA; Pasman JW; Hendricks HT; Schelhaas JH; Zwarts MJ; Geurts AC
J Clin Neurophysiol; 2007 Dec; 24(6):450-5. PubMed ID: 18090526
[TBL] [Abstract][Full Text] [Related]
16. Cortical dysfunction underlies disability in multiple sclerosis.
Vucic S; Burke T; Lenton K; Ramanathan S; Gomes L; Yannikas C; Kiernan MC
Mult Scler; 2012 Apr; 18(4):425-32. PubMed ID: 21965421
[TBL] [Abstract][Full Text] [Related]
17. Axonal changes in spinal cord injured patients distal to the site of injury.
Lin CS; Macefield VG; Elam M; Wallin BG; Engel S; Kiernan MC
Brain; 2007 Apr; 130(Pt 4):985-94. PubMed ID: 17264094
[TBL] [Abstract][Full Text] [Related]
18. Ipsilateral silent period: a marker of callosal conduction abnormality in early relapsing-remitting multiple sclerosis?
Jung P; Beyerle A; Humpich M; Neumann-Haefelin T; Lanfermann H; Ziemann U
J Neurol Sci; 2006 Dec; 250(1-2):133-9. PubMed ID: 17011585
[TBL] [Abstract][Full Text] [Related]
19. Physiological measures of therapeutic response to interferon beta-1a treatment in remitting-relapsing MS.
White AT; Petajan JH
Clin Neurophysiol; 2004 Oct; 115(10):2364-71. PubMed ID: 15351379
[TBL] [Abstract][Full Text] [Related]
20. How effective are disease-modifying drugs in delaying progression in relapsing-onset MS?
Brown MG; Kirby S; Skedgel C; Fisk JD; Murray TJ; Bhan V; Sketris IS
Neurology; 2007 Oct; 69(15):1498-507. PubMed ID: 17699802
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
